Suppr超能文献

对输尿管囊肿治疗趋势的研究并未得出明确的解决方案。

Examining trends in the treatment of ureterocele yields no definitive solution.

作者信息

Cohen S A, Juwono T, Palazzi K L, Kaplan G W, Chiang G

机构信息

Department of Urology, UC San Diego Health System, 200 West Arbor Dr. #8897, San Diego, CA 92103-8897, USA.

Department of Urology, UC San Diego Health System, 200 West Arbor Dr. #8897, San Diego, CA 92103-8897, USA; Pediatric Urology, Rady Children's Hospital-San Diego, 3020 Children's Way, MC 5056, San Diego, CA 92123, USA.

出版信息

J Pediatr Urol. 2015 Feb;11(1):29.e1-6. doi: 10.1016/j.jpurol.2014.09.001. Epub 2014 Oct 2.

Abstract

INTRODUCTION

The surgical management of ureteroceles is extremely variable. Some have hypothesized that if these patients were treated with 'definitive' staged surgical intervention, the need for further revision surgery would be eliminated.

OBJECTIVE

The present study sought to determine if the rate of revision surgery differed among patients who have undergone different surgical approaches for the ureterocele complex.

STUDY DESIGN

A large retrospective chart review was conducted, identifying all patients having undergone ureterocele surgery at a single institution over the past 41 years. The cohort was divided into four groups based on surgical approach: upper tract approach (UTA), lower tract reconstruction (LTR), simultaneous upper and lower tract approach (ULTA), and staged lower tract reconstruction (SLTR). Demographics, the presence of preoperative/postoperative VUR, postoperative morbidity and the need for revision surgery were compared using the Chi- squared test, Fisher's exact test, Kruskal-Wallis test, Mann-Whitney U test (Bonferroni correction), logistic regression modeling and survival analyses (Kaplan-Meier and Cox proportional Hazards regression with unplanned revision operation as the outcome event).

RESULTS

Between 1969 and 2010, 180 patients were identified as having undergone surgical management of ureteroceles, of which 120 had complete demographic data available for analysis. The median age at the time of initial surgical intervention was 5.8 months and the majority of patients (83.3%) were female. The median follow-up was 33.1 months. Surgical management was as follows: 18 (15.0%) patients underwent UTA, 47 (39.2%) underwent LTR, 23 (19.2%) underwent ULTA, and 32 (26.6%) underwent SLTR. Among these groups, the only difference in median age was between the LTR and SLTR groups (6.3 months vs 3.7 months, P=0.012). Additional revision surgery was required in: nine (50.0%) of UTA, ten (21.3%) of LTR, four (17.4%) of ULTA, and three (9.4%) of SLTR. The only statistically significant difference in unplanned revision surgery was noted in the UTA group versus each of the other groups with VUR as the predominant indication (88.9%). The likelihood of requiring revision surgery in comparison to the SLTR group was significantly increased in the UTA group (OR 9.67, CI 2.15-43.56), but not in the LTR (OR 2.61, CI 0.66-10.37) or the ULTA group (OR 2.04, CI 0.41-10.13). Obstruction, recurring UTIs and VUR were the main indications for revision surgery overall.

DISCUSSION

There is a large body of literature examining the surgical management of ureteroceles. It most recently primarily focuses on an endoscopic approach to the lower tract. The present retrospective review examined the need for re-operative intervention by comparing four different surgical approaches, and found that there is no panacea. Although heminephrectomy (UTA) was a definitive procedure in some patients without reflux at presentation, many who underwent heminephrectomy, went on to require later bladder surgery for either recurrent UTI or persistent reflux. The present study has multiple limitations. Although VUR was an indication for revision surgery in the early part of the series, the current treatment of VUR is not necessarily as stringent. In addition, no distinction was made between an orthotopic or ectopic ureterocele, although some authors have reported differing outcomes in these two groups. However, it is felt that given the large data set of a relatively uncommon condition, the lack of superiority of one approach is apparent.

CONCLUSION

There is no definitive surgical repair for the ureterocele complex. All groups except UTA had statistically similar rates of revision surgery. The widespread variability in current management echoes the lack of one superior approach found in this comprehensive series.

摘要

引言

输尿管囊肿的手术治疗方法极为多样。一些人推测,如果对这些患者采用“确定性”的分期手术干预,那么进一步的翻修手术需求将得以消除。

目的

本研究旨在确定接受不同手术方法治疗输尿管囊肿复合体的患者中,翻修手术的发生率是否存在差异。

研究设计

进行了一项大型回顾性病历审查,确定了过去41年在单一机构接受输尿管囊肿手术的所有患者。根据手术方法将队列分为四组:上尿路入路(UTA)、下尿路重建(LTR)、上下尿路同时入路(ULTA)和分期下尿路重建(SLTR)。使用卡方检验、费舍尔精确检验、克鲁斯卡尔 - 沃利斯检验、曼 - 惠特尼U检验(邦费罗尼校正)、逻辑回归模型和生存分析(以计划外翻修手术为结局事件的卡普兰 - 迈耶法和考克斯比例风险回归)比较人口统计学数据、术前/术后膀胱输尿管反流(VUR)的存在情况、术后发病率以及翻修手术的需求。

结果

在1969年至2010年期间,确定有180例患者接受了输尿管囊肿的手术治疗,其中120例有完整的人口统计学数据可供分析。初次手术干预时的中位年龄为5.8个月,大多数患者(83.3%)为女性。中位随访时间为33.1个月。手术治疗情况如下:18例(15.0%)患者接受UTA,47例(39.2%)接受LTR,23例(19.2%)接受ULTA,32例(26.6%)接受SLTR。在这些组中,中位年龄的唯一差异存在于LTR组和SLTR组之间(分别为6.3个月和3.7个月,P = 0.012)。需要额外翻修手术的情况如下:UTA组9例(50.0%),LTR组10例(21.3%),ULTA组4例(17.4%),SLTR组3例(9.4%)。在计划外翻修手术中,唯一具有统计学显著差异的是UTA组与其他各组相比,以VUR为主要指征(88.9%)。与SLTR组相比,UTA组需要翻修手术的可能性显著增加(比值比9.67,可信区间2.15 - 43.56),但LTR组(比值比2.61,可信区间0.66 - 10.37)或ULTA组(比值比2.04,可信区间0.41 - 10.13)并非如此。梗阻、复发性尿路感染和VUR是总体翻修手术的主要指征。

讨论

有大量文献探讨输尿管囊肿的手术治疗。最近主要集中在内镜下处理下尿路。本回顾性研究通过比较四种不同的手术方法,考察了再次手术干预的必要性,发现没有万无一失的方法。虽然半肾切除术(UTA)对一些初发时无反流的患者是一种确定性手术,但许多接受半肾切除术的患者后来因复发性尿路感染或持续性反流而需要进行膀胱手术。本研究有多个局限性。虽然在该系列研究早期VUR是翻修手术的一个指征,但目前对VUR的治疗不一定如此严格。此外,未区分原位或异位输尿管囊肿,尽管一些作者报告这两组的结果有所不同。然而,鉴于相对罕见疾病的大量数据集,一种方法缺乏优越性是显而易见的。

结论

对于输尿管囊肿复合体,没有确定性的手术修复方法。除UTA组外,所有组的翻修手术发生率在统计学上相似。当前管理的广泛差异反映了在这个综合系列研究中未发现一种优越方法的情况。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验